A Program to Evaluate Riastap and FIBTEM for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)

Trial Profile

A Program to Evaluate Riastap and FIBTEM for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Fibrinogen (Primary)
  • Indications Postpartum haemorrhage
  • Focus Pharmacodynamics
  • Acronyms PERFECT PPH
  • Most Recent Events

    • 23 Aug 2016 Planned initiation date changed from 1 Sep 2015 to 1 Sep 2016.
    • 22 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top